Log in to save to my catalogue

Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunos...

Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunos...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_088d4cc36e7f4cb896d7b35e92e017a6

Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on IL17 , RORγt , IL4 and GATA3 gene expressions in rheumatoid arthritis patients

About this item

Full title

Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on IL17 , RORγt , IL4 and GATA3 gene expressions in rheumatoid arthritis patients

Publisher

New Zealand: Dove Medical Press

Journal title

Drug design, development and therapy, 2017-03, Vol.11, p.1027-1033

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press

More information

Scope and Contents

Contents

Rheumatoid arthritis (RA) is the most common form of chronic inflammatory arthritis characterized by pain, swelling and destruction of joints, with a resultant disability. Disease-modifying anti-rheumatic drugs (DMARDs) and biological drugs can interfere with the disease process. In this study, the effect of β-d-mannuronic acid (M2000) as a novel n...

Alternative Titles

Full title

Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on IL17 , RORγt , IL4 and GATA3 gene expressions in rheumatoid arthritis patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_088d4cc36e7f4cb896d7b35e92e017a6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_088d4cc36e7f4cb896d7b35e92e017a6

Other Identifiers

ISSN

1177-8881

E-ISSN

1177-8881

DOI

10.2147/DDDT.S129419

How to access this item